Search Results

build Virtual Reality solutions for Scientists and Engineers working at the nanoscale, specifically protein

regulation of axonal transport by tricyclic antidepressants (M.Sc.) and molecular pharmacology of opioid receptors Marc Caron, where I cloned the dopamine D5 receptor gene and investigated the regulation of dopaminergic and adrenergic receptors. pursues the study of the molecular, structural, pharmacological and signaling features of dopamine (DA) receptors druggability potential of new signaling partners we identified that drive the formation of different DA receptor

Paul Clarck , where she studied opioid receptors. AstraZeneca as a postdoctoral trainee, where she studied animal models of pain and sensory neuron sensitive-receptor Brigitte Kieffer , where she studied ligand-directed signaling at the delta-opioid receptor. Amynah studied how arrestins regulate ligand-directed signaling at delta-opioid receptors, and it is Andrew Charles that who specialized in animal models of migraine and delta-opioid receptors as a therapeutic

AI is reshaping how we understand protein dynamics , but only when driven by deep biological questions behind founding Blue Therapeutics and targeting supraspinal pain pathway What it means to “teach AI protein

Fung has spent significant time in the industry studying membrane proteins, antibodies, and HTS methods

in his independent laboratory is focused on developing new pharmacological tools via chemistry and protein

But during a summer internship in protein purification, he faced a harsh reality: lab work wasn’t his

Celtarys’ innovative chemical biology tools, making it easier than ever for scientists to study ligand-receptor Celtarys’ innovative chemical biology tools , making it easier than ever for scientists to study ligand-receptor

pharmacologist and biophysicist, systems and synthetic biologist, technologist, heavy CRISPR user, protein

graduate school at the University of California at Irvine, studying the regulation of ionotropic glutamate receptors , Oregon, to do a post-doctoral fellowship in the laboratory of Thomas Soderling studying glutamate receptor continued his post-doctoral training at Duke University, where he studied the regulation of adrenergic receptors contributions to understanding the signaling, regulation and in vivo actions of the neuroprotective receptors Randy’s lab has a special interest in studying disease-associated mutations to human GPCRs that perturb receptor

doctoral dissertation was the first large-scale study of structure-activity relationships for adenosine receptors postdoc with John W Daly at NIH and Solomon Snyder at Johns Hopkins, he developed the first adenosine receptor He then joined WL/PD, where his lab demonstrated the existence of two subtypes of the adenosine A2 receptor In 1988, he joined Lilly as a receptor biologist in charge of a high-throughput screening lab.

Uppsala University is redefining GPCR drug discovery with predictive molecular modeling that forecasts receptor Their lab doesn’t just simulate receptor-ligand interactions after the fact; they aim to forecast receptor

Surprisingly, arrestin’s finger loop didn’t dive into the receptor core. Surprisingly, arrestin’s finger loop didn’t dive into the receptor core.

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor

Following this tremendous experience, he was recruited to be the Principal Investigator of the Receptor To broaden his biomedical skill-set Stuart next accepted the position of Head of the Receptor Pharmacology Stuart’s current research, in the Receptor Biology Lab, focuses on the development of novel GPCR-based Stuart Maudsley on the web Maudsley Lab LinkedIn Google Scholar ResearchGate Maudsley Lab on Facebook Receptor

Aaron is currently the Chief Scientific Officer and VP of Protein Engineering. Aaron has a proven track record as a biologics leader as he led teams to discover and develop novel first-in-class

His lab has worked on building large-scale ways of empirically exploring questions in protein biochemistry

They’re kinetic game-changers—compounds that rewrite the relationship between ligand, receptor, and physiologic Understanding how persistent binding affects receptor turnover, tissue penetration, and PK/PD relationships Inhibition In GPCR Discovery Programs Every drug you design will meet an enzyme before it meets its receptor Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Before your GPCR ligand ever meets its receptor

They’re kinetic game-changers—compounds that rewrite the relationship between ligand, receptor, and physiologic Understanding how persistent binding affects receptor turnover, tissue penetration, and PK/PD relationships Inhibition In GPCR Discovery Programs Every drug you design will meet an enzyme before it meets its receptor Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Before your GPCR ligand ever meets its receptor

They’re kinetic game-changers—compounds that rewrite the relationship between ligand, receptor, and physiologic Understanding how persistent binding affects receptor turnover, tissue penetration, and PK/PD relationships Inhibition In GPCR Discovery Programs Every drug you design will meet an enzyme before it meets its receptor Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Before your GPCR ligand ever meets its receptor

Professor Pfleger has developed extensive expertise in profiling receptor binding and function at the globally-recognized expertise in bioluminescence resonance energy transfer (BRET) technology, including his patented Receptor-Heteromer Investigation Technology (Receptor-HIT) for studying heteromers.

Samuel Hoare Sam completed his Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors life science, and academic scientists in the development of new therapeutics and the understanding of receptor about his love for GPCRs, kinetics, and decorticate the complexities of GPCR function to better target receptors

They’re kinetic game-changers—compounds that rewrite the relationship between ligand, receptor, and physiologic Understanding how persistent binding affects receptor turnover, tissue penetration, and PK/PD relationships Inhibition In GPCR Discovery Programs Every drug you design will meet an enzyme before it meets its receptor Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Before your GPCR ligand ever meets its receptor

They’re kinetic game-changers—compounds that rewrite the relationship between ligand, receptor, and physiologic Understanding how persistent binding affects receptor turnover, tissue penetration, and PK/PD relationships Inhibition In GPCR Discovery Programs Every drug you design will meet an enzyme before it meets its receptor Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Before your GPCR ligand ever meets its receptor

They’re kinetic game-changers—compounds that rewrite the relationship between ligand, receptor, and physiologic Understanding how persistent binding affects receptor turnover, tissue penetration, and PK/PD relationships Inhibition In GPCR Discovery Programs Every drug you design will meet an enzyme before it meets its receptor Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery Before your GPCR ligand ever meets its receptor

Jens Carlsson challenges scientists to go beyond explaining data — and start predicting the future of receptor With tools like AlphaFold , his lab can now model receptor–peptide complexes in seconds — an achievement Yet Jens’s caution stands: prediction must be proven.

GPCR Retreat Program < Back to schedule Structure-based discovery of functionally selective 5-HT1A receptor

and worked closely with Dr Birgitte Holst studying structural and mechanistic properties of ghrelin receptor associated with obesity and other metabolic diseases, including GPR10, Melanocortin 4, Serotonin 2C and TRH receptors cell-based in vitro technologies to study mechanistic properties of GPCRs and understanding the dynamics of receptor Jacek shared his fascination with the growth hormone secretion receptor and the melanocortin 4 receptor Yamina, in turn, talked about her work on melanocortin receptors and an upcoming collaboration with a

Pluznick discovered that olfactory receptors in mice are also expressed in their kidneys and blood vessels GPCRs in regulating renal and cardiovascular function, and identifying renal/cardiovascular olfactory receptor